These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 12227166)
1. [Anti-viral immune responses against hepatitis C virus]. Imawari M Uirusu; 2002 Jun; 52(1):151-6. PubMed ID: 12227166 [No Abstract] [Full Text] [Related]
2. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses. Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093 [TBL] [Abstract][Full Text] [Related]
3. Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens. Kuzushita N; Gregory SH; Monti NA; Carlson R; Gehring S; Wands JR Gastroenterology; 2006 Feb; 130(2):453-64. PubMed ID: 16472599 [TBL] [Abstract][Full Text] [Related]
4. Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine. Memarnejadian A; Roohvand F Cell Immunol; 2010; 261(2):93-8. PubMed ID: 20056196 [TBL] [Abstract][Full Text] [Related]
5. [Forecasting of hepatitis C virus CTL epitopes and design of multi-epitopes vaccine]. Li D; Xie YW; Xue XP; Bai XF; Jia ZS Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):786-7. PubMed ID: 19874698 [No Abstract] [Full Text] [Related]
6. [Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches]. Stoll-Keller F; Schvoerer E; Thumann C; Navas MC; Aubertin AM Bull Acad Natl Med; 2003; 187(6):1147-60; discussion 1160-1. PubMed ID: 14978874 [TBL] [Abstract][Full Text] [Related]
7. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence. Hiroishi K; Ito T; Imawari M J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560 [TBL] [Abstract][Full Text] [Related]
9. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia. Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177 [TBL] [Abstract][Full Text] [Related]
10. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Kita H; Moriyama T; Kaneko T; Harase I; Nomura M; Miura H; Nakamura I; Yazaki Y; Imawari M Hepatology; 1993 Nov; 18(5):1039-44. PubMed ID: 7693568 [TBL] [Abstract][Full Text] [Related]
11. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins. Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603 [TBL] [Abstract][Full Text] [Related]
12. Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: tetramer assay and therapeutic implications. Tsai SL; Sheen IS; Chien RN; Chu CM; Huang HC; Chuang YL; Lee TH; Liao SK; Lin CL; Kuo GC; Liaw YF J Biomed Sci; 2003; 10(1):120-35. PubMed ID: 12566993 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids. Geissler M; Gesien A; Wands JR J Immunol; 1997 Nov; 159(10):5107-13. PubMed ID: 9366440 [TBL] [Abstract][Full Text] [Related]
14. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA. Yu H; Babiuk LA; van Drunen Littel-van den Hurk S Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490 [TBL] [Abstract][Full Text] [Related]
15. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40. Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104 [TBL] [Abstract][Full Text] [Related]
16. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA. Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465 [TBL] [Abstract][Full Text] [Related]
17. Protective immunity against hepatitis C virus infection. Elliot LN; Lloyd AR; Ziegler JB; Ffrench RA Immunol Cell Biol; 2006 Jun; 84(3):239-49. PubMed ID: 16509830 [TBL] [Abstract][Full Text] [Related]
18. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550 [TBL] [Abstract][Full Text] [Related]
19. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. Nelson DR; Marousis CG; Davis GL; Rice CM; Wong J; Houghton M; Lau JY J Immunol; 1997 Feb; 158(3):1473-81. PubMed ID: 9013994 [TBL] [Abstract][Full Text] [Related]
20. Dendritic cell subsets and the regulation of Th1/Th2 responses. Maldonado-López R; Moser M Semin Immunol; 2001 Oct; 13(5):275-82. PubMed ID: 11502162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]